Related references
Note: Only part of the references are listed.Delivery of STING agonists for adjuvanting subunit vaccines
Simon Van Herck et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Pharmacological Activation of cGAS for Cancer Immunotherapy
Kyle M. Garland et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Ji Wang et al.
SCIENCE (2020)
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
Rebekah Watkins-Schulz et al.
BIOMATERIALS (2019)
STING pathway agonism as a cancer therapeutic
Blake A. Flood et al.
IMMUNOLOGICAL REVIEWS (2019)
A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination
Robert D. Junkins et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine
Catharine I. Paules et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy
Naihan Chen et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
Michael A. Collier et al.
MOLECULAR PHARMACEUTICS (2018)
Physical activation of innate immunity by spiky particles
Ji Wang et al.
NATURE NANOTECHNOLOGY (2018)
Acetalated Dextran: A Tunable and Acid-Labile Biopolymer with Facile Synthesis and a Range of Applications
Eric M. Bachelder et al.
CHEMICAL REVIEWS (2017)
Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age
Lisa M. Dunkle et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice
Kai Schulze et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways
Alessandra Zevini et al.
TRENDS IN IMMUNOLOGY (2017)
Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses
Luuk A. Th. Hilgers et al.
VACCINE (2017)
Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets
Sang-Mu Shim et al.
VACCINE (2017)
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
Tyler J. Goodwin et al.
VACCINE (2017)
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine
Nicholas C. Wu et al.
PLOS PATHOGENS (2017)
Mucosal administration of cycle-Di-nucleotide-adjuvanted Virosomes efficiently induces Protection against influenza H5N1 in Mice
Thomas Ebensen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Sandeep T. Koshy et al.
ADVANCED BIOSYSTEMS (2017)
Submicron-sized hydrogels incorporating cyclic dinucleotides for selective delivery and elevated cytokine release in macrophages
Eunjoo Lee et al.
ACTA BIOMATERIALIA (2016)
Natural STING Agonist as an Ideal Adjuvant for Cutaneous Vaccination
Ji Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface
Melissa Samo et al.
VACCINE (2016)
Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant
Matthew D. Gallovic et al.
BIOMATERIALS SCIENCE (2016)
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine et al.
CHEMICAL REVIEWS (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2015)
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
Beatris Mastelic Gavillet et al.
JOURNAL OF IMMUNOLOGY (2015)
A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy
Hiroko Miyabe et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
Maria Victoria Sanchez et al.
PLOS ONE (2014)
Cyclic GMP-AMP Displays Mucosal Adjuvant Activity in Mice
Ivana Skrnjug et al.
PLOS ONE (2014)
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
Charles Maisonneuve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung
Vanessa Neuhaus et al.
VACCINE (2014)
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
Signe C. Svindland et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING
Xu Zhang et al.
MOLECULAR CELL (2013)
Efficient Delivery of the Toll-like Receptor Agonists Polyinosinic:Polycytidylic Acid and CpG to Macrophages by Acetalated Dextran Microparticles
Kevin J. Peine et al.
MOLECULAR PHARMACEUTICS (2013)
Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia
Katrin Hoegner et al.
PLOS PATHOGENS (2013)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Synthesis and Characterization of Acetalated Dextran Polymer and Microparticles with Ethanol as a Degradation Product
Kevin J. Kauffman et al.
ACS APPLIED MATERIALS & INTERFACES (2012)
Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions
Naveen Kanthamneni et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection
Dimitrios G. Koutsonanos et al.
SCIENTIFIC REPORTS (2012)
The ferret as a model organism to study influenza A virus infection
Jessica A. Belser et al.
DISEASE MODELS & MECHANISMS (2011)
Comparative Analyses of Pandemic H1N1 and Seasonal H1N1, H3N2, and Influenza B Infections Depict Distinct Clinical Pictures in Ferrets
Stephen S. H. Huang et al.
PLOS ONE (2011)
Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
Gabriel Kristian Pedersen et al.
PLOS ONE (2011)
Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice
Abdullah S. Madhun et al.
VACCINE (2011)
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy
Kyle E. Broaders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Acetal-derivatized dextran:: An acid-responsive biodegradable material for therapeutic applications
Eric M. Bachelder et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Role of particle size in phagocytosis of polymeric microspheres
Julie A. Champion et al.
PHARMACEUTICAL RESEARCH (2008)
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection
Derek T. O'Hagan
EXPERT REVIEW OF VACCINES (2007)
Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor
Nikhil S. Joshi et al.
IMMUNITY (2007)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Microparticles and nanoparticles for drug delivery
Daniel S. Kohane
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Role of target geometry in phagocytosis
JA Champion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The ferret: An animal model to study influenza virus
JA Maher et al.
LAB ANIMAL (2004)
Share Paper
